Type 2 Diabetes and ADP Receptor Blocker Therapy

Type 2 diabetes (T2D) is associated with several abnormalities in haemostasis predisposing to thrombosis. Moreover, T2D was recently connected with a failure in antiplatelet response to clopidogrel, the most commonly used ADP receptor blocker in clinical practice. Clopidogrel high on-treatment plate...

Descripción completa

Detalles Bibliográficos
Autores principales: Samoš, Matej, Fedor, Marián, Kovář, František, Mokáň, Michal, Bolek, Tomáš, Galajda, Peter, Kubisz, Peter, Mokáň, Marián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707344/
https://www.ncbi.nlm.nih.gov/pubmed/26824047
http://dx.doi.org/10.1155/2016/6760710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707344/
https://www.ncbi.nlm.nih.gov/pubmed/26824047
http://dx.doi.org/10.1155/2016/6760710

Ejemplares similares